Soluble serum interleukin 2 receptor levels in leprosy patients. 1987

K S Tung, and E Umland, and P Matzner, and K Nelson, and V Schauf, and L Rubin, and D Wagner, and D Scollard, and P Vithayasai, and V Vithayasai
Department of Pathology, University of New Mexico School of Medicine, Albuquerque 87131.

Soluble interleukin 2 receptors (IL-2R) in sera of leprosy patients from Chiang Mai, Thailand, were quantified with a solid phase enzyme immunoassay using two monoclonal antibodies to the IL-2R. The IL-2R levels of untreated lepromatous, borderline lepromatous or midborderline patients and treated lepromatous and borderline lepromatous or treated borderline tuberculoid and tuberculoid patients were comparable to those of the Thai household or nonhousehold contacts; and they were significantly higher than the levels of USA control subjects. In contrast, IL-2R of untreated tuberculoid or borderline tuberculoid patients were significantly reduced. Patients with ongoing reversal reaction had very high circulating IL-2R, the levels of which correlated with fever and extent of skin lesions. Although erythema nodosum leprosum patients also had elevated IL-2R levels, they were significantly below those of patients with reversal reaction. When treated with corticosteroid, precipitous reduction of IL-2R was noted in all patients with reversal reaction but not in patients with erythema nodosum leprosum.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D004893 Erythema Nodosum An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D015375 Receptors, Interleukin-2 Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN. IL-2 Receptors,Interleukin-2 Receptor,Interleukin-2 Receptors,Receptors, IL-2,Receptors, T-Cell Growth Factor,T-Cell Growth Factor Receptors,IL-2 Receptor,IL2 Receptor,IL2 Receptors,Interleukin 2 Receptor,Receptor, TCGF,T-Cell Growth Factor Receptor,TCGF Receptor,TCGF Receptors,IL 2 Receptor,IL 2 Receptors,Interleukin 2 Receptors,Receptor, IL-2,Receptor, IL2,Receptor, Interleukin 2,Receptor, Interleukin-2,Receptors, IL 2,Receptors, IL2,Receptors, Interleukin 2,Receptors, T Cell Growth Factor,Receptors, TCGF,T Cell Growth Factor Receptor,T Cell Growth Factor Receptors

Related Publications

K S Tung, and E Umland, and P Matzner, and K Nelson, and V Schauf, and L Rubin, and D Wagner, and D Scollard, and P Vithayasai, and V Vithayasai
January 1995, The Journal of asthma : official journal of the Association for the Care of Asthma,
K S Tung, and E Umland, and P Matzner, and K Nelson, and V Schauf, and L Rubin, and D Wagner, and D Scollard, and P Vithayasai, and V Vithayasai
April 1998, Anales de medicina interna (Madrid, Spain : 1984),
K S Tung, and E Umland, and P Matzner, and K Nelson, and V Schauf, and L Rubin, and D Wagner, and D Scollard, and P Vithayasai, and V Vithayasai
August 1993, Arerugi = [Allergy],
K S Tung, and E Umland, and P Matzner, and K Nelson, and V Schauf, and L Rubin, and D Wagner, and D Scollard, and P Vithayasai, and V Vithayasai
June 1998, Yan ke xue bao = Eye science,
K S Tung, and E Umland, and P Matzner, and K Nelson, and V Schauf, and L Rubin, and D Wagner, and D Scollard, and P Vithayasai, and V Vithayasai
March 1997, Breast cancer (Tokyo, Japan),
K S Tung, and E Umland, and P Matzner, and K Nelson, and V Schauf, and L Rubin, and D Wagner, and D Scollard, and P Vithayasai, and V Vithayasai
April 1990, The Journal of pediatrics,
K S Tung, and E Umland, and P Matzner, and K Nelson, and V Schauf, and L Rubin, and D Wagner, and D Scollard, and P Vithayasai, and V Vithayasai
January 1994, Anxiety,
K S Tung, and E Umland, and P Matzner, and K Nelson, and V Schauf, and L Rubin, and D Wagner, and D Scollard, and P Vithayasai, and V Vithayasai
August 2016, Postepy dermatologii i alergologii,
K S Tung, and E Umland, and P Matzner, and K Nelson, and V Schauf, and L Rubin, and D Wagner, and D Scollard, and P Vithayasai, and V Vithayasai
January 1996, Hepato-gastroenterology,
K S Tung, and E Umland, and P Matzner, and K Nelson, and V Schauf, and L Rubin, and D Wagner, and D Scollard, and P Vithayasai, and V Vithayasai
January 1990, The Korean journal of internal medicine,
Copied contents to your clipboard!